Walker-Warburg syndrome synonyms

Walker-Warburg syndrome (WWS) is a severe form of congenital muscular dystrophy characterized by brain and eye abnormalities, historically known by several names including HARD syndrome or cerebro-ocular-muscular syndrome. Because it represents a spectrum of dystroglycanopathies, medical professionals now prefer the specific term Walker-Warburg syndrome, though older literature may still use various clinical descriptors based on the specific constellation of symptoms present in a patient.

Why does Walker-Warburg syndrome have multiple names?

The nomenclature for Walker-Warburg syndrome has evolved significantly as our understanding of its genetic basis has improved. In the past, clinicians often named the condition based on its primary clinical features, leading to terms like "cerebro-ocular-muscular syndrome." As researchers identified that Walker-Warburg syndrome is part of a broader group of disorders called dystroglycanopathies—caused by mutations in genes like POMT1, POMT2, and FKTN—the medical community moved toward using the eponymous name to standardize diagnostic reporting. The presence of multiple historical names often causes confusion for families researching the condition in older medical journals or international records.

What are the common synonyms and historical terms for WWS?

When reviewing medical records or historical literature, you may encounter several alternative terms for Walker-Warburg syndrome. These names were often used to highlight specific clinical presentations, such as the combination of hydrocephalus, agyria, and retinal dysplasia:

• HARD syndrome: An acronym for Hydrocephalus, Agyria, and Retinal Dysplasia.


• Cerebro-ocular-muscular syndrome: A descriptive term highlighting the three primary organ systems affected.


• Warburg syndrome: A simplified eponym often used in older European literature.


• Chemke syndrome: A rare, historical reference named after the researchers who described similar clinical features.


• Congenital muscular dystrophy with brain and eye anomalies: A broad clinical description used in some international classification systems.

How is the condition classified in official medical systems?

For clinical documentation and research purposes, Walker-Warburg syndrome is categorized under specific codes to ensure consistency across global healthcare systems. Using these codes can be helpful when communicating with insurance providers or specialists:

1. Orphanet: Classified under ORPHA:901, listed as Walker-Warburg syndrome.


2. OMIM (Online Mendelian Inheritance in Man): The primary entry is #236670, which serves as the definitive genetic reference for the condition.


3. ICD-10/ICD-11: While there is no single unique code exclusively for Walker-Warburg syndrome, it is typically coded under "Congenital muscular dystrophy" or "Other specified disorders of brain development."

Which name is preferred by medical professionals today?

Today, Walker-Warburg syndrome is the universally accepted terminology in clinical genetics and neurology. While the term "dystroglycanopathy" is used to describe the underlying biological mechanism, the specific diagnosis remains Walker-Warburg syndrome. At DiseaseMaps.org, 14 community members have identified with this specific diagnosis, highlighting the importance of using the standardized name to connect with others in the rare disease community. Using the official name ensures that your medical records align with current international standards and facilitates accurate information sharing between your care team and genetic specialists.

Next steps

• Consult with a clinical geneticist to confirm the specific genetic mutation, as this often provides more precision than clinical names alone.


• Request that your primary care physician use the OMIM code #236670 in your electronic health records for billing and specialist referrals.


• Connect with the 14 families in the DiseaseMaps.org community to share resources and experiences regarding specialized care.


• Visit the NIH Genetic and Rare Diseases (GARD) Information Center website for the most recent updates on clinical research trials.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment from a qualified healthcare provider.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: Walker-Warburg syndrome overview.


• Orphanet: Portal for rare diseases and orphan drugs (ORPHA:901).


• OMIM (Online Mendelian Inheritance in Man): Entry #236670.


• PubMed/NCBI: Reviews on the genetic spectrum of dystroglycanopathies.